a2 Milk FY2026 revenue rises 12.4% to NZ$1.975b, Chinese-label formula gets premium boost

Summary

a2 Milk's FY2026 revenue rose 12.4% to NZ$1.975 billion, with the company targeting NZ$2 billion in FY2027.

Commentary

a2 Milk's FY2026 revenue growth of 12.4% to NZ$1.975 billion was underpinned by strong China and Asia sales of NZ$1.448 billion, yet infant formula sales rose only 4.7% — a fraction of the 59.9% growth in the broader family nutrition range. That gap reflects a strategic pivot away from a shrinking newborn segment in China and toward growth areas such as adult milk powder, children's UHT milk and nutritional supplements. The company's first-mover position in A2 protein liquid milk globally is paying off, with North American sales up 28.6% and validating brand spillover.

For NZ's small and medium dairy processors, a2's category expansion points to opportunities in adult nutrition and functional dairy, where local milk quality and contract manufacturing can feed cross-border channels. But the slowdown in infant formula is a caution against single-category reliance, compounded by the high barrier of China's formula registration rules. More realistic bets for smaller players lie in supplying specialty ingredients or co-developing differentiated products with larger brands.

With dairy tariffs already essentially eliminated under the NZ-China FTA, demand for liquid milk and flavoured milk remains steady. a2's guidance of NZ$2 billion revenue in FY2027, along with its local procurement, could open fresh cooperation windows.

Keywords: a2 Milk Company, Fiscal Year 2026, revenue growth, NZ$1.975 billion, whole family nutrition products, revenue target of NZ$2 billion, China and Asia, North America, infant formula powder, liquid milk

Source: Caijing